U.K. switches benzocaine, nicotine sprays
This article was originally published in The Tan Sheet
Executive Summary
The country's Medicines and Healthcare Products regulatory Authority switches benzocaine throat spray (1 mg) to general sale (similar to OTC in the U.S.) in the U.K. to relieve sore throat pain in adults and children 6 years and older. The regulatory agency March 24 also switched nicotine nasal spray, including McNeil's Nicorette nasal spray, to general sale to help consumers older than 12 stop smoking